In total, 56 lipids and non-physiological analogs were selected from the KEGG database (Kanehisa et al, 2008) . The first column provides the lipid name and the second one the abbreviation used in the present study. The non-physiological lipids are labeled with an #. The lipid classification by metabolic pathway and the chemical classification reported in Lipid MAPS (Fahy et al, 2005) are given in columns three and four respectively. Lipid supplier is indicated in column five. When available, every arrayed lipid is identified with its KEGG ID and PUBCHEM compound ID in columns six and seven respectively. Alternatively, for lipid composed by more than one molecular specie (i.e. purified from natural sources) PUBCHEM substance ID is given in column seven. Column eighth lists the LogP value estimated for each lipid using the algorithm described by Cheng et al ., 2007 (Cheng et al, 2007 . Last column lists the overall charge calculated for each lipid using Marvin 5.2.3_2 (ChemAxon, 2009) . For those lipids composed of more than one molecular specie, a representative specie was chosen for the LogP and charge calculation. In this case, PUBCHEM compound ID is given in brackets. In total, 172 were selected. The first and second columns give the systematic ORF and gene names, respectively. Third column gives the Uniprot (The UniProt Consortium, 2008) accession number for one of the predicted human orthologs. The presence of LBDs and protein classification are given in column four. When available, we also include information on affinity (Kd) for binding to a particular lipid binding in column five; the source PubMed reference is indicated in column six. The annotation "Domain" indicates experiments performed with truncated domains. An estimation of the level of TAP-fusion expression in yeast cells is represented in a scale from 1 (lowest) to 5 (highest) in column seven. Finally, TAP-tagged proteins expressed in E. coli are indicated with a "+" in column eight. The matrix consists of 530 protein-lipid interactions. First and second columns give the systematic ORF and gene names. The third column indicates LBDs and protein classification. The first row lists the 56 lipids analyzed. Those interactions that did not appear in two duplicates were discarded from the consolidated dataset. The interactions for those lipids that were excluded for further analysis are shown separately. Interactions reported for Slm1-PH expressed in E. coli are also shown. Non-physiological lipids are labeled with an #.
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Nic96 The matrix consists of 530 protein-lipid interactions and their supporting evidence. First and second columns give the systematic ORF and gene names. The third column indicates LBDs and protein classification. The first row lists the 44 lipids remaining after removing those lipids excluded for further analysis.Those interactions that did not appear in two duplicates were discarded from the consolidated dataset. Non-physiological lipids are labeled with an #. Supporting evidence are letter coded according to the protein-lipid interaction is supported by: R, Replicates with the lipid-array; E, recombinant protein expressed in E. coli; G, Genetic interactions; S, sphingolipid depletion with Myriocin; P, PtdInsPs depletion with Mss4 ts ; L, Liposome based assays.
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Osh6 OBP The first and second columns give the systematic ORF and gene names. The third column lists the reported interactions and the name of the interacting lipids, with the estimated Kd when available. For enzymes, a simple representation of the reaction is shown. Finally, the fourth column collects the publication (PubMed ID) where the respective interaction (or enzymatic reaction) was reported. 
Inositol phosphate metabolism
The matrix consists of 328 described genetic interactions between 172 analyzed proteins (rows) and 96 enzymes involved in lipid metabolism (columns). The first and second columns give the systematic ORF and gene names, respectively. Enzymes are grouped by metabolic pathways. The gene names for lipid metabolic enzymes are described in brackets. Genetic interactions were collected from literature and SGD database. SGD annotation was employed to classify the different genetic interactions types. Note that for simplicity the following groups were defined and represented with a letter code: C, Chemical Genetics; D, Dosage Dependent Interaction (Dosage rescue + Dosage Growth defect + Dosage lethality); P, Positive Suppressive Genetics (Positive genetics + Synthetic rescue + Phenotypic Suppression); N, Negative Synthetic Genetics (Negative genetics + Synthetic lethality + Synthetic growth defect). Numbers refer to the literature source of the published interactions (see legend on top left corner of the matrix). Note that for reference PMID:20093466 the stringent threshold was used PtdIns(4)P 0
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